|
FNDC3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11299969240974E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3941000021056E-08 |
| Normal-vs-Stage2 |
2.771900E-04 |
| Normal-vs-Stage3 |
6.9265000002261E-07 |
| Normal-vs-Stage4 |
7.67729999573419E-08 |
| Stage1-vs-Stage2 |
6.714400E-01 |
| Stage1-vs-Stage3 |
2.899400E-01 |
| Stage1-vs-Stage4 |
1.393580E-01 |
| Stage2-vs-Stage3 |
7.237400E-01 |
| Stage2-vs-Stage4 |
5.582200E-01 |
| Stage3-vs-Stage4 |
8.295200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.7576052552547E-11 |
| Normal-vs-AfricanAmerican |
1.623860E-02 |
| Normal-vs-Asian |
1.206170E-01 |
| Caucasian-vs-AfricanAmerican |
5.377400E-03 |
| Caucasian-vs-Asian |
6.637800E-01 |
| AfricanAmerican-vs-Asian |
3.201000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25459997946109E-09 |
| Normal-vs-Female |
2.78659995078812E-09 |
| Male-vs-Female |
7.805400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.216080E-02 |
| Normal-vs-Age(41-60Yrs) |
1.04629971353631E-10 |
| Normal-vs-Age(61-80Yrs) |
1.83120000274428E-08 |
| Normal-vs-Age(81-100Yrs) |
2.171000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.636600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.136400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.633500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.662400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.963900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.925600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.76690000000179E-05 |
| Normal-vs-Grade 2 |
2.15930000546649E-08 |
| Normal-vs-Grade 3 |
3.46749995383533E-09 |
| Normal-vs-Grade 4 |
4.89219999999513E-06 |
| Grade 1-vs-Grade 2 |
3.491400E-01 |
| Grade 1-vs-Grade 3 |
2.032600E-01 |
| Grade 1-vs-Grade 4 |
5.705200E-01 |
| Grade 2-vs-Grade 3 |
8.888400E-01 |
| Grade 2-vs-Grade 4 |
5.029600E-01 |
| Grade 3-vs-Grade 4 |
4.364800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.23410004437829E-09 |
| Normal-vs-ccB subtype |
1.43120004736375E-09 |
| ccA subtype-vs-ccB subtype |
2.694600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.13849970854119E-10 |
| Normal-vs-N1 |
7.537700E-03 |
| N0-vs-N1 |
1.581160E-01 |
|
|
